INGR Stock Analysis: Ingredion | NYSE
Packaged Foods | NYSE, USA | Market Cap: 6.030m USD | 12M Return: -25.4% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 102M
EPS Trend: 85.2%
Qual. Beats: 0
Rev. Trend: -96.7%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Ingredion Incorporated (NYSE: INGR) is a global ingredient solutions company that manufactures and sells sweeteners, starches, nutrition ingredients, and biomaterial solutions derived from wet milling and processing of corn and other starch-based materials. Founded in 1906 and headquartered in Westchester, Illinois, the company was formerly known as Corn Products International, Inc. before adopting its current name in June 2012. Ingredion operates through three reportable segments: Texture & Healthful Solutions, Food & Industrial Ingredients-LATAM, and Food & Industrial Ingredients-U.S./Canada.
The company serves a diverse, business-to-business customer base across food and beverage, paper, textile, pharmaceutical, cosmetics, construction, and industrial applications. Its product portfolio includes glucose and high fructose corn syrups, dextrose, maltodextrins, polyols, cornstarch, specialty industrial starches, refined corn oil, corn gluten feed, and corn gluten meal. Ingredion also supplies starches used in biomaterial applications such as biodegradable plastics, detergents, and personal care products.
As a member of the Consumer Staples sector, specifically the Agricultural Products & Services sub-industry, Ingredion benefits from the relatively inelastic demand for food inputs, which provides some insulation from economic cycles. The corn wet milling process is capital-intensive and yields multiple co-products-starch, sweeteners, oil, and feed ingredients-enabling the company to spread fixed costs across a broad product mix and a global customer base.
- Corn cost volatility pressures sweetener gross margins
- LATAM currency headwinds pressure reported revenue growth
- Specialty Texture & Healthful Solutions mix lifts margins
| Net Income: 674.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA -3.65 > 1.0 |
| NWC/Revenue: 31.23% < 20% (prev 29.66%; Δ 1.57% < -1%) |
| CFO/TA 0.11 > 3% & CFO 900.0m > Net Income 674.0m |
| Net Debt (1.09b) to EBITDA (1.16b): 0.94 < 3 |
| Current Ratio: 2.76 > 1.5 & < 3 |
| Outstanding Shares: last quarter (64.4m) vs 12m ago -1.83% < -2% |
| Gross Margin: 24.49% > 18% (prev 25.00%; Δ -0.50% > 0.5%) |
| Asset Turnover: 93.50% > 50% (prev 98.57%; Δ -5.06% > 0%) |
| Interest Coverage Ratio: 25.43 > 6 (EBIT TTM 941.0m / Interest Expense TTM 37.0m) |
| A: 0.28 (Total Current Assets 3.52b - Total Current Liabilities 1.28b) / Total Assets 7.93b |
| B: 0.72 (Retained Earnings 5.70b / Total Assets 7.93b) |
| C: 0.12 (EBIT TTM 941.0m / Avg Total Assets 7.70b) |
| D: 1.27 (Book Value of Equity 4.42b / Total Liabilities 3.48b) |
| Altman-Z'' = 6.36 = AAA |
| DSRI: 1.08 (Receivables 1.36b/1.28b, Revenue 7.20b/7.36b) |
| GMI: 1.02 (GM 25.00% / 24.49%) |
| AQI: 0.96 (AQ_t 0.23 / AQ_t-1 0.24) |
| SGI: 0.98 (Revenue 7.20b / 7.36b) |
| TATA: -0.03 (NI 674.0m - CFO 900.0m) / TA 7.93b) |
| Beneish M = -2.98 (Cap -4..+1) = A |
As of July 08, 2026, the stock is trading at USD 98.57 with a total of 809,710 shares traded. Over the past week, the price has changed by +4.21%, over one month by -0.23%, over three months by -12.26% and over the past year by -25.44%.
Current recommended Stop Loss: 95.40 (which is 3.2% or 1.3 ATR below the current price).
Ingredion has received a consensus analysts rating of 3.71. Therefore, it is recommended to hold INGR.
- StrongBuy: 2
- Buy: 1
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 122.8 | 24.6% |
P/E Trailing = 9.1942
P/E Forward = 8.7108
P/S = 0.8377
P/B = 1.35
P/EG = 1.1769
Revenue TTM = 7.20b USD
EBIT TTM = 941.0m USD
EBITDA TTM = 1.16b USD
Long Term Debt = 1.74b USD (from longTermDebt, last quarter)
Short Term Debt = 83.0m USD (from shortTermDebt, last quarter)
Debt = 2.01b USD (from shortLongTermDebtTotal, last quarter) + Leases 181.0m
Net Debt = 1.09b USD (calculated: Debt 2.01b - CCE 918.0m)
Enterprise Value = 7.12b USD (6.03b + Debt 2.01b - CCE 918.0m)
Interest Coverage Ratio = 25.43 (Ebit TTM 941.0m / Interest Expense TTM 37.0m)
EV/FCF = 9.53x (Enterprise Value 7.12b / FCF TTM 747.0m)
FCF Yield = 10.49% (FCF TTM 747.0m / Enterprise Value 7.12b)
FCF Margin = 10.38% (FCF TTM 747.0m / Revenue TTM 7.20b)
Net Margin = 9.36% (Net Income TTM 674.0m / Revenue TTM 7.20b)
Gross Margin = 24.49% ((Revenue TTM 7.20b - Cost of Revenue TTM 5.43b) / Revenue TTM)
Gross Margin QoQ = 22.38% (prev 24.47%)
Tobins Q-Ratio = 0.90 (Enterprise Value 7.12b / Total Assets 7.93b)
Interest Expense / Debt = 1.84% (Interest Expense 37.0m / Debt 2.01b)
Taxrate = 24.42% (220.0m / 901.0m)
NOPAT = 711.2m (EBIT 941.0m * (1 - 24.42%))
Current Ratio = 2.76 (Total Current Assets 3.52b / Total Current Liabilities 1.28b)
Debt / Equity = 0.45 (Debt 2.01b / totalStockholderEquity, last quarter 4.42b)
Debt / EBITDA = 0.94 (Net Debt 1.09b / EBITDA 1.16b)
Debt / FCF = 1.46 (Net Debt 1.09b / FCF TTM 747.0m)
Total Stockholder Equity = 4.33b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.76% (Net Income 674.0m / Total Assets 7.93b)
RoE = 15.57% (Net Income TTM 674.0m / Total Stockholder Equity 4.33b)
RoCE = 15.50% (EBIT 941.0m / Capital Employed (Equity 4.33b + L.T.Debt 1.74b))
RoIC = 11.16% (NOPAT 711.2m / Invested Capital 6.37b)
WACC = 5.26% (E(6.03b)/V(8.04b) * Re(6.54%) + D(2.01b)/V(8.04b) * Rd(1.84%) * (1-Tc(0.24)))
Discount Rate = 6.54% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -76.83 | Cagr: -1.35%
[DCF] Terminal Value 73.10% ; FCFF base≈838.6m ; Y1≈735.4m ; Y5≈594.2m
[DCF] Fair Price = 134.0 (EV 9.54b - Net Debt 1.09b = Equity 8.45b / Shares 63.1m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 85.16 | EPS CAGR: 11.01% | SUE: -0.49 | # QB: 0
Revenue Correlation: -96.70 | Revenue CAGR: -5.43% | SUE: 0.13 | # QB: 0
EPS current Quarter (2026-06-30): EPS=2.76 | Chg30d=+0.00% | Revisions=-44% | Analysts=6
EPS next Quarter (2026-09-30): EPS=2.89 | Chg30d=+0.00% | Revisions=-67% | Analysts=6
EPS current Year (2026-12-31): EPS=10.82 | Chg30d=+0.00% | Revisions=-70% | GrowthEPS=-2.8% | GrowthRev=+0.5%
EPS next Year (2027-12-31): EPS=11.61 | Chg30d=+0.00% | Revisions=-70% | GrowthEPS=+7.2% | GrowthRev=+3.2%
[Analyst] Revisions Ratio: -83% (up=1, down=25)